This site is intended for health professionals only

Editor’s pick

Novartis gains rights to oral targeted investigational therapies
Novartis gains rights to oral targeted investigational therapies
Shire submits application for velaglucerase alfa
Shire submits application for velaglucerase alfa
Glaxo seeks prostate-drug update
Glaxo seeks prostate-drug update
Roche champions Avastin for NHS use
Roche champions Avastin for NHS use
Vioxx stroke link “known in 2000”
Vioxx stroke link “known in 2000”
Novartis inaugurates flu cell culture vaccine facility
Novartis inaugurates flu cell culture vaccine facility
Tamiflu-resistant swine flu infects patients in Wales, UK
Tamiflu-resistant swine flu infects patients in Wales, UK
Gene-cancer link may aid treatment
Gene-cancer link may aid treatment
Morphine “promotes cancer growth”
Morphine “promotes cancer growth”
Avastin not recommended for treatment of GBM
Avastin not recommended for treatment of GBM
Agreement reached over largest-ever study of antimalarial drug
Agreement reached over largest-ever study of antimalarial drug
Results from study with Xarelto to be presented at ASH 2009
Results from study with Xarelto to be presented at ASH 2009
1 … 98 99 100 101 102 … 302





Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2026
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x